6794 — Unicocell Biomed Co Income Statement
0.000.00%
Last trade - 00:00- TWD3.83bn
- TWD3.34bn
- TWD31.88m
Annual income statement for Unicocell Biomed Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.98 | 8.18 | 14.4 | 24.6 | 31.9 |
| Cost of Revenue | |||||
| Gross Profit | 2.34 | 5.83 | 8.2 | 17.9 | 20.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 115 | 95.5 | 107 | 121 | 135 |
| Operating Profit | -111 | -87.3 | -92.1 | -96.3 | -103 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -109 | -86.4 | -91.2 | -84.1 | -93.1 |
| Net Income After Taxes | -109 | -86.4 | -91.2 | -84.1 | -93.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -109 | -86.4 | -91.2 | -84.1 | -93.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -109 | -86.4 | -91.2 | -84.1 | -93.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.05 | -2.27 | -2.2 | -1.65 | -1.63 |
| Dividends per Share |